MANEJO DE LAS NAÚSEAS Y VÓMITOS EN EL EMBARAZO. CONSENSO DE LA FEDERACIÓN COLOMBIANA DE ASOCIACIONES DE PERINATOLOGÍA (FECOPEN). BOGOTÁ, 2016

  • Saulo Molina Giraldo FECOPEN
  • David Vásquez Awad FECOPEN
  • Jesús Andrés Benavides Serralde FECOPEN
  • José María Aramendiz FECOPEN
  • Gustavo Adolfo Vásquez Zapata FECOPEN
  • Marcela Buitrago Leal FECOPEN
Palabras clave: Nauseas, vómito, embarazo, hiperemesis Gravídica, Nausea, vomiting, pregnancy, Hyperemesis.

Resumen

Introducción: Las nauseas y vómito del embarazo (NVE) son descritas como una condición común que afecta a la salud de la mujer embarazada y a su feto. Contribuye de manera significativa a los costos de salud y pérdida de tiempo laboral. El objetivo de este consenso es brindar al lector los elementos de juicio que a la luz de la evidencia, permitan enfocar de manera integral la patología, diagnosticarla y brindar el esquema de tratamiento más pertinente, con el fin de identificar las potenciales complicaciones de la entidad.Materiales y métodos: La FECOPEN convocó a una reunión de expertos nacionales, con el propósito de realizar un consenso no formal de expertos basados en una revisión de la literatura para identificar la información más relevante con respecto a las Definiciones, Epidemiología, Patogénesis, Hiperémesis Gravídica, Diagnóstico, Diagnóstico Diferencial, Morbilidad Materna, Resultados Perinatales y Esquemas de Tratamiento.Resultados: 79 artículos fueron incluidos para el análisis final así: Epidemiología 10, patogénesis 10, Hiperémesis gravídica 26, diagnóstico 10, Morbilidad materno fetal 19, tratamiento 9. Algunos artículos fueron utilizados para diferentes ítems.Conclusión: es una entidad multifactorial que requiere un manejo integral. Se propone un esquema práctico de fácil seguimiento.CONSENSUS OF THE COLOMBIAN FEDERATION OF PERINATOLOGY ASSOCIATIONS (FECOPEN). MANAGEMENT OF NAUSEA AND VOMITING OF PREGNANCY, BOGOTÁ 2016.ABSTRACTIntroduction: Nausea and vomiting of pregnancy (NVE) is described as a common condition that affects health of the pregnant woman and the fetus. It contributes significantly to health care costs and lost working time. The objective of this agreement is to provide the reader with evidence that allows to focus holistically pathology, to diagnose and provide the most appropriate treatment scheme in order to identify potential complications of the entity.Materials and methods: the FECOPEN convened a meeting of national experts in order to conduct a non formal consensus based on literature review to identify the most relevant regarding definitions, epidemiology, pathogenesis, Hyperemesis gravidarum, diagnosis, differential diagnosis, maternal morbidity, perinatal outcomes information and treatment schemes.Results: 79 items were included for final analysis: epidemiology (10), pathogenesis (10), Hyperemesis gravidarum (26), diagnosis (10) maternal fetal morbidity, treatment (9). Some of them were used for different items.Conclusion: This is a multifactorial disease that requires a comprehensive management. A practical easy guideline scheme is proposed.

Biografía del autor

Saulo Molina Giraldo, FECOPEN
MD, MSc. Presidente Federación Colombiana de Asociaciones de Perinatología – FECOPEN; Past President Asociación Bogotana de Perinatología. Jefe Unidad Materno Fetal de la clínica de la mujer y de la Unidad Materno Fetal de la clínica Materno Infantil Colsubsidio; Director programa de especialización Medicina Materno fetal hospital de San José- FUCS, Bogotá, Colombia.
David Vásquez Awad, FECOPEN
MD, FACOG. Ginecólogo y obstetra, perinatólogo, epidemiólogo y especialista en Seguridad Social. Miembro del Consejo de la Facultad de Medicina Universidad Javeriana. Miembro Junta Directiva de la Academia Nacional de Medicina. Fellow del American College of Obstericians and Gynecologists. Bogotá, Colombia.
Jesús Andrés Benavides Serralde, FECOPEN
MD, PhD ©. Doctorado en Ginecología y Obstetricia en la Universidad de Barcelona – Hospital Clínic, en el Departamento de Medicina Materno Fetal. Presidente de la Asociación de Medicina Perinatal de Risaralda (AMPER); miembro Junta directiva de la FECOPEN; Coordinador del Comité de Morbilidad Perinatal de la Federación Colombiana de Sociedades de Obstetricia y Ginecología (FECOLSOG). Pereira, Risaralda.
José María Aramendiz, FECOPEN
MD. Especialista en Medicina Materno Fetal en la Fundación Universitaria de ciencias de la Salud, Hospital de San José. Docente Alto Riesgo Obstétrico Universidad de Sucre. Miembro de Número FECOPEN. Unidad de Medicina Materno Fetal Clínica Salud Social, Sincelejo, Sucre.
Gustavo Adolfo Vásquez Zapata, FECOPEN
MD, Ginecólogo y Obstetra. Especialista en Perinatología y Desarrollo Humano, CLAP. Docente de Posgrado, Universidad Libre de Cali.
Marcela Buitrago Leal, FECOPEN
MD. Especialista en Medicina Materno Fetal, Epidemiologia Clínica con el convenio CES – Universidad del Rosario. Unidad Materno fetal Clínica de la Mujer y la Clínica de Country en Bogotá, Vicepresidente de la Asociación Bogotana de Perinatología y miembro de la Junta directiva de FECOPEN. Bogotá, Colombia.

Citas

1. Denis C. Doctissimo 2016. Tomado de: www.salud. doctissimo.es/diccionariomedico.
2. Colombia ANdMd. Diccionario Académico de la Me- dicina 2016. Tomado de: www.dic.idiomamedico.net
3. Mazzotta P, Magee LA. A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy. Drugs. 2000;59(4):781-800.
4. Herrell HE. Nausea and vomiting of pregnancy. Am Fam Physician. 2014;89(12):965-70.
5. Niebyl JR. Clinical practice. Nausea and vomiting in pregnancy. N Engl J Med. 2010;363(16):1544-50.
6. Taylor Tricia. Treatment of nausea and vomiting in pregnancy. Australian Prescriber 2014;47:42-5.
7. Haro K, Toledo K, Fonseca Y, Arenas D, Arenas H, Leonher K. Hiperemesis gravídica: manejo y conse- cuencias nutricionales; reporte de caso y revisión de literatura. Nutrición Hospitalaria . 2015; 31(2): 988-91 pp.
8. Enrique ZFC. Náuseas y vómitos durante el em- barazo. Revista Centroamericana de Obstetricia y Ginecología. 2010;15(2): 40-9.
9. Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Epidemiology of nausea and vomiting of pregnancy: prevalence, severity, determinants, and the impor- tance of race/ethnicity. BMC Pregnancy Childbirth. 2009;9:26.
10. Lee NM, Saha S. Nausea and vomiting of pregnancy. Gastroenterol Clin North Am. 2011;40(2):309-34, vii.
11. Cardaropoli S, Rolfo A, Todros T. Helicobacter pylori and pregnancy-related disorders. World J Gastroen- terol. 2014;20(3):654-64.
12. McCarthy FP, Lutomski JE, Greene RA. Hypereme- sis gravidarum: current perspectives. Int J Womens Health. 2014;6:719-25.
13. Shaban MM, Kandil HO, Elshafei AH. Helicobacter pylori seropositivity in patients with hyperemesis gravidarum. Am J Med Sci. 2014;347(2):101-5.
14. Mansour GM, Nashaat EH. Role of Helicobacter pylori in the pathogenesis of hyperemesis gravidarum. Arch Gynecol Obstet. 2011;284(4):843-7.
15. Li L, Zhou X, Xiao S, Gu H, Zhang G. Helicobacter pylori Infection Is Associated with an Increased Risk of Hyperemesis Gravidarum: A Meta-Analysis. Gastroenterol Res Pract. 2015;2015:278905.16. Cardwell MS. Pregnancy sickness: a biopsychological perspective. Obstet Gynecol Surv. 2012;67(10):645- 52.
17. Tan PC, Zaidi SN, Azmi N, Omar SZ, Khong SY. Depression, anxiety, stress and hyperemesis gra- vidarum: temporal and case controlled correlates. PLoS One. 2014;9(3):e92036.
18. Ramya RS, Jayanthi N, Alexander PC, Vijaya S, Jayanthi V. Gastroesophageal reflux disease in pregnancy: a longitudinal study. Trop Gastroenterol. 2014;35(3):168-72.
19. Riezzo G, Pezzolla F, Darconza G, Giorgio I. Gastric myoelectrical activity in the first trimester of preg- nancy: a cutaneous electrogastrographic study. Am J Gastroenterol. 1992;87(6):702-7.
20. Nuangchamnong N, Niebyl J. Doxylamine succinate- pyridoxine hydrochloride (Diclegis) for the mana- gement of nausea and vomiting in pregnancy: an overview. Int J Womens Health. 2014;6:401-9.
21. Matthews A, Haas DM, O’Mathúna DP, Dowswell T. Interventions for nausea and vomiting in early pregnan- cy. Cochrane Database Syst Rev. 2015(9):CD007575.
22. Klebanoff MA, Koslowe PA, Kaslow R, Rhoads GG. Epidemiology of vomiting in early pregnancy. Obstet Gynecol. 1985;66(5):612-6.
23. Gideon K, Herbert W, Gooswn T M. Nausea and vomiting of pregnancy. APOG eductional series on Wommen`s health issues. 2011:1-26.
24. Heinrichs L. Linking olfaction with nausea and vomi- ting of pregnancy, recurrent abortion, hyperemesis gravidarum, and migraine headache. Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S215-9.
25. Basso O, Olsen J. Sex ratio and twinning in women with hyperemesis or pre-eclampsia. Epidemiology. 2001;12(6):747-9.
26. Brandes JM. First-trimester nausea and vomiting as related to outcome of pregnancy. Obstet Gynecol. 1967;30(3):427-31.
27. Hou JL, Wan XR, Xiang Y, Qi QW, Yang XY. Changes of clinical features in hydatidiform mole: analysis of 113 cases. J Reprod Med. 2008;53(8):629-33.
28. Emelianova S, Mazzotta P, Einarson A, Koren G. Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation. Clin Invest Med. 1999;22(3):106-10.
29. Czeizel AE, Dudas I, Fritz G, Técsöi A, Hanck A, Kunovits G. The effect of periconceptional multivi- tamin-mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Arch Gynecol Obstet. 1992;251(4):181-5.
30. Gill SK, Maltepe C, Koren G. The effect of heartburn and acid reflux on the severity of nausea and vomiting of pregnancy. Can J Gastroenterol. 2009;23(4):270-2.
31. Buckwalter JG, Simpson SW. Psychological factors in the etiology and treatment of severe nausea and vomiting in pregnancy. Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S210-4.
32. Matteson S, Roscoe J, Hickok J, Morrow GR. The role of behavioral conditioning in the development of nausea. Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S239-43.
33. Lagiou P, Tamimi R, Mucci LA, Trichopoulos D, Adami HO, Hsieh CC. Nausea and vomiting in pregnancy in relation to prolactin, estrogens, and progesterone: a prospective study. Obstet Gynecol. 2003;101(4):639- 44.
34. O’Leary P, Boyne P, Flett P, Beilby J, James I. Lon- gitudinal assessment of changes in reproductive hormones during normal pregnancy. Clin Chem. 1991;37(5):667-72.
35. Kimura M, Amino N, Tamaki H, Ito E, Mitsuda N, Miyai K, et al. Gestational thyrotoxicosis and hyperemesis gravidarum: possible role of hCG with higher stimula- ting activity. Clin Endocrinol (Oxf). 1993;38(4):345-50.
36. Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab. 1992;75(5):1333-7.
37. Soules MR, Hughes CL, Garcia JA, Livengood CH, Prystowsky MR, Alexander E. Nausea and vomiting of pregnancy: role of human chorionic gonadotro- pin and 17-hydroxyprogesterone. Obstet Gynecol. 1980;55(6):696-700.
38. Brzana RJ, Koch KL. Gastroesophageal reflux disease presenting with intractable nausea. Ann Intern Med. 1997;126(9):704-7.
39. Niemeijer MN, Grooten IJ, Vos N, Bais JM, van der Post JA, Mol BW, et al. Diagnostic markers for hyperemesis gravidarum: a systematic review and metaanalysis. Am J Obstet Gynecol. 2014;211(2):150. e1-15.
40. Goodwin TM. Nausea and vomiting of pregnancy: an obstetric syndrome. Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S184-9.
41. Koren G, Boskovic R, Hard M, Maltepe C, Navioz Y, Einarson A. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S228-31.
42. Lacasse A, Rey E, Ferreira E, Morin C, Bérard A.
Validity of a modified Pregnancy-Unique Quantifica- tion of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2008;198(1):71.e1-7.
43. Ashkenazi-Hoffnung L, Merlob P, Stahl B, Klinger G. Evaluation of the efficacy and safety of bi-daily combination therapy with pyridoxine and doxylamine for nausea and vomiting of pregnancy. Isr Med Assoc J. 2013;15(1):23-6.
44. De la Torre Bulnes M. Complicaciones gastrointestinales en el embarazo. Clases de Residentes 2007, Servicio de Obstetricia y Ginecología Hospital Universitario Virgen de las Nieves Granada. 2007:1- 29.
45. Niebyl JR, Briggs GG. The pharmacologic manage- ment of nausea and vomiting of pregnancy. J Fam Pract. 2014;63(2 Suppl):S31-7.
46. Yeo ST, Holdcroft A, Yentis SM, Stewart A, Bassett P. Analgesia with sevoflurane during labour: ii. Sevo- flurane compared with Entonox for labour analgesia. Br J Anaesth. 2007;98(1):110-5.
47. Madjunkova S, Maltepe C, Koren G. The delayed- release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nau- sea and vomiting of pregnancy. Paediatr Drugs. 2014;16(3):199-211.
48. Maltepe C, Koren G. Preemptive treatment of nausea and vomiting of pregnancy: results of a randomized controlled trial. Obstet Gynecol Int. 2013;2013:809787.
49. Anderka M, Mitchell AA, Louik C, Werler MM, Hernández-Diaz S, Rasmussen SA, et al. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2012;94(1):22-30.
50. Nieby JR. Nausea and vomiting in pregnancy. The New England Journal of Medicina. 2010;363: 1544 - 50
51. Louik C, Hernandez-Diaz S, Werler MM, Mitchell AA. Nausea and vomiting in pregnancy: maternal characteristics and risk factors. Paediatr Perinat Epidemiol. 2006;20(4):270-8.
52. Lacroix R, Eason E, Melzack R. Nausea and vomiting during pregnancy: A prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol. 2000;182(4):931-7.
53. Di Gangi S, Gizzo S, Patrelli TS, Saccardi C, D’Antona D, Nardelli GB. Wernicke’s encephalopathy com- plicating hyperemesis gravidarum: from the back- ground to the present. J Matern Fetal Neonatal Med. 2012;25(8):1499-504.
54. Mathew M, Mohan AK, Jacob PC. Hyperemesis gravidarum complicated by Wernicke`s encephalopathy. Neurosciences (Riyadh). 2007;12(3):267-8.
55. Nguyen N, Deitel M, Lacy E. Splenic avulsion in a pregnant patient with vomiting. Can J Surg. 1995;38(5):464- 5.
56. Liang SG, Ooka F, Santo A, Kaibara M. Pneumome- diastinum following esophageal rupture associated with hyperemesis gravidarum. J Obstet Gynaecol Res. 2002;28(3):172-5.
57. Russo-Stieglitz KE, Levine AB, Wagner BA, Armenti VT. Pregnancy outcome in patients requiring paren- teral nutrition. J Matern Fetal Med. 1999;8(4):164-7.
58. Golberg D, Szilagyi A, Graves L. Hyperemesis gravi- darum and Helicobacter pylori infection: a systematic review. Obstet Gynecol. 2007;110(3):695-703.
59. Goodwin TM. Hyperemesis gravidarum. Clin Obstet Gynecol. 1998;41(3):597-605.
60. Simpson SW, Goodwin TM, Robins SB, Rizzo AA, Howes RA, Buckwalter DK, et al. Psychological factors and hyperemesis gravidarum. J Womens Health Gend Based Med. 2001;10(5):471-7.
61. Zhang J, Cai WW. Severe vomiting during pregnancy: antenatal correlates and fetal outcomes. Epidemiology. 1991;2(6):454-7.
62. Järnfelt-Samsioe A, Eriksson B, Waldenström J, Samsioe G. Some new aspects on emesis gravida- rum. Relations to clinical data, serum electrolytes, total protein and creatinine. Gynecol Obstet Invest. 1985;19(4):174-86.
63. Chin RK. Nausea and vomiting of early pregnancy and pregnancy outcome. An epidemiological study. Br J Obstet Gynaecol. 1990;97(3):278.
64. Veenendaal MV, van Abeelen AF, Painter RC, van der Post JA, Roseboom TJ. Consequences of hypere- mesis gravidarum for offspring: a systematic review and meta-analysis. BJOG. 2011;118(11):1302-13.
65. Practice Bulletin No. 153: Nausea and Vomiting of Pregnancy. Obstet Gynecol. 2015;126(3):e12-24.
66. Palacio M. Guía Clínica: Hiperemesis Gravídica. Protocolos Medicina Fetal y Perinatal - Servei de Medicina Maternofetal – ICGON 2014:1-4.
67. Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med. 2010;363(22):2114-23.
68. Viljoen E, Visser J, Koen N, Musekiwa A. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutr J. 2014;13:20.
69. Ebrahimi N, Maltepe C, Einarson A. Optimal mana- gement of nausea and vomiting of pregnancy. Int J Womens Health. 2010;2:241-8.
70. EinarsonA, Maltepe C, Boskovic R, Koren G. Treatment of nausea and vomiting in pregnancy: an updated algorithm. Can Fam Physician. 2007;53(12):2109-11.
71. Clark SM, Costantine MM, Hankins GD. Review of NVP and HG and Early Pharmacotherapeutic Intervention. Obstet Gynecol Int. 2012;2012:252676.
72. Maltepe C, Koren G. The management of nausea and vomiting of pregnancy and hyperemesis gravi- darum--a 2013 update. J Popul Ther Clin Pharmacol.
2013;20(2):e184-92.
Publicado
2016-04-30